- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有81家主力机构披露2025-06-30报告期持股数据，持仓量总计3.87亿股，占流通A股69.23%
- 波段诊断：
-
技术面诊股
诊断结果：5.1技术面打败了23%的股票
技术面评分前10的股票
近期的平均成本为14.83元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为14.83元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.83","date":1758095956,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2025.09.18","stock":"-0.87","trade":"-1.21","ind":"-1.06"},{"date":"2025.09.17","stock":"-0.60","trade":"-0.25","ind":"1.16"},{"date":"2025.09.16","stock":"-0.13","trade":"0.68","ind":"0.45"},{"date":"2025.09.15","stock":"-0.73","trade":"-0.41","ind":"0.63"},{"date":"2025.09.12","stock":"0.27","trade":"-0.31","ind":"-0.43"},{"date":"2025.09.11","stock":"0.40","trade":"0.43","ind":"3.36"},{"date":"2025.09.10","stock":"-0.13","trade":"0.02","ind":"0.38"},{"date":"2025.09.09","stock":"-0.66","trade":"-1.27","ind":"-1.23"},{"date":"2025.09.08","stock":"1.41","trade":"1.30","ind":"0.61"},{"date":"2025.09.05","stock":"0.95","trade":"1.12","ind":"3.89"},{"date":"2025.09.04","stock":"-0.81","trade":"-0.37","ind":"-2.83"},{"date":"2025.09.03","stock":"-0.54","trade":"-1.55","ind":"-0.65"},{"date":"2025.09.02","stock":"-0.73","trade":"-1.12","ind":"-2.14"},{"date":"2025.09.01","stock":"-0.33","trade":"1.10","ind":"1.05"},{"date":"2025.08.29","stock":"0.13","trade":"-0.16","ind":"0.99"},{"date":"2025.08.28","stock":"-0.72","trade":"-0.71","ind":"2.25"},{"date":"2025.08.27","stock":"-2.19","trade":"-2.68","ind":"-1.43"},{"date":"2025.08.26","stock":"-0.06","trade":"-0.03","ind":"0.26"},{"date":"2025.08.25","stock":"0.58","trade":"0.83","ind":"2.26"},{"date":"2025.08.22","stock":"-1.28","trade":"-0.41","ind":"2.07"},{"date":"2025.08.21","stock":"-0.13","trade":"-0.21","ind":"-0.06"}]
桂林三金,深证成指,中药指数
压力支撑
该股压力位为14.80元，支撑位为14.65元。
[{"text":"\u538b\u529b\u4f4d","value":"14.80","date":1758124800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.65","date":1758124800,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.6资金面打败了79%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：09月18日 20:30
| 机构今日流向(万元) | -2359.67 | 机构5日流向(万元) | -8575.48 |
| 机构10日流向(万元) | -11739.93 | 机构20日流向(万元) | -40480.22 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加311.90万股，其中基金净减仓5家，主力净减仓27家，暂未发现中长期投资价值。
截止2025-06-30，共81家主力机构（基金78家，一般法人3家），持仓量总计38704.76万股，占流通A股69.23%
其中，基金持仓与2024-12-31相比：
增仓：13家 ，增持 65.69万股
减仓：18家 ，减持 180.32万股
新出现在主力名单中：43家 ，持有565.9万股
从主力名单中消失：70家 ，原持有378.11万股
其中，基金持仓与2024-12-31相比：
增仓：13家 ，增持 65.69万股
减仓：18家 ，减持 180.32万股
新出现在主力名单中：43家 ，持有565.9万股
从主力名单中消失：70家 ，原持有378.11万股
消息面诊股
诊断结果：5.9消息面打败了15%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 桂林三金：9月17日获融资买入523.15万元
2025-09-18 - 桂林三金：BC006单抗注射液项目即将完成I期临床
2025-09-17 - 桂林三金：宝船生物为研发基地，聚焦肿瘤和自身免疫性
2025-09-17 - 桂林三金：机构调研之后是否会出具研报或者购买公司股
2025-09-17 - 桂林三金：9月16日获融资买入363.66万元
2025-09-17 - 桂林三金：9月15日获融资买入272.87万元
2025-09-16 - 桂林三金：9月12日获融资买入309.81万元，占
2025-09-15 - 行业追踪|中医药市场（9月8日-9月14日）：综合
2025-09-14 - 桂林三金：9月11日获融资买入425.11万元，占
2025-09-12 - 桂林三金（截止2025年9月10日）股东人数为21
2025-09-11
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-29 |
| 一般消息 | 募资投向 | 2025-08-05 | |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-26 |
| 利好 | 分红转增 | 10派3.5元(含税) | 2025-04-26 |
| 一般消息 | 高管变动 | 连续担任公司独立董事即将满六年 | 2025-04-11 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2024-10-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.1行业面打败了73%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.09.18","price":"-1.06","value":"-1.21"},{"date":"2025.09.17","price":"1.16","value":"-0.25"},{"date":"2025.09.16","price":"0.45","value":"0.68"},{"date":"2025.09.15","price":"0.63","value":"-0.41"},{"date":"2025.09.12","price":"-0.43","value":"-0.31"},{"date":"2025.09.11","price":"3.36","value":"0.43"},{"date":"2025.09.10","price":"0.38","value":"0.02"},{"date":"2025.09.09","price":"-1.23","value":"-1.27"},{"date":"2025.09.08","price":"0.61","value":"1.30"},{"date":"2025.09.05","price":"3.89","value":"1.12"},{"date":"2025.09.04","price":"-2.83","value":"-0.37"},{"date":"2025.09.03","price":"-0.65","value":"-1.55"},{"date":"2025.09.02","price":"-2.14","value":"-1.12"},{"date":"2025.09.01","price":"1.05","value":"1.10"},{"date":"2025.08.29","price":"0.99","value":"-0.16"},{"date":"2025.08.28","price":"2.25","value":"-0.71"},{"date":"2025.08.27","price":"-1.43","value":"-2.68"},{"date":"2025.08.26","price":"0.26","value":"-0.03"},{"date":"2025.08.25","price":"2.26","value":"0.83"},{"date":"2025.08.22","price":"2.07","value":"-0.41"},{"date":"2025.08.21","price":"-0.06","value":"-0.21"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 46.18% | 16.18% | 6.0分 |
| 2 | 康美药业 | 4.83% | 7.43% | 6.2分 |
| 3 | - | 4.39% | 4.39% | 分 |
| 4 | 天目药业 | 3.89% | -1.25% | 5.5分 |
| 5 | 以岭药业 | 2.04% | -5.16% | 5.6分 |
| 6 | 云南白药 | 1.72% | -2.22% | 5.7分 |
| 8 | ST香雪 | 0.63% | -0.09% | 4.3分 |
| 10 | 中恒集团 | 0.35% | 5.09% | 6.3分 |
| 12 | 太龙药业 | -1.35% | -1.64% | 4.8分 |
| 14 | 盘龙药业 | -1.55% | 2.28% | 5.7分 |
| 16 | ST葫芦娃 | -2.76% | -1.19% | 4.3分 |
| 18 | 莱茵生物 | -2.93% | -0.25% | 5.6分 |
| 20 | 信邦制药 | -3.72% | -1.63% | 5.4分 |
| 22 | 奇正藏药 | -4.18% | -2.91% | 6.2分 |
| 24 | 康恩贝 | -4.49% | -1.54% | 5.5分 |
| 26 | 东阿阿胶 | -4.67% | -3.12% | 4.8分 |
| 28 | 华润三九 | -4.85% | -1.58% | 5.6分 |
| 30 | 康惠制药 | -4.99% | -2.11% | 4.3分 |
| 32 | 汉森制药 | -5.22% | -4.11% | 4.8分 |
| 34 | 精华制药 | -5.37% | -2.76% | 4.9分 |
| 36 | 吉林敖东 | -5.67% | -3.54% | 4.8分 |
| 38 | 同仁堂 | -5.92% | -1.10% | 4.7分 |
| 40 | 佛慈制药 | -6.23% | -2.84% | 4.8分 |
| 42 | 特一药业 | -6.45% | -0.78% | 5.7分 |
| 44 | 粤万年青 | -7.13% | -3.15% | 4.9分 |
| 46 | 马应龙 | -7.21% | -2.42% | 5.1分 |
| 48 | 珍宝岛 | -7.58% | -3.06% | 5.0分 |
| 50 | 益盛药业 | -7.81% | -2.22% | 4.7分 |
| 52 | 贵州百灵 | -8.59% | -4.17% | 4.2分 |
| 54 | 华森制药 | -8.64% | -1.33% | 5.9分 |
| 56 | 广誉远 | -9.14% | -4.03% | 5.2分 |
| 58 | 上海凯宝 | -9.45% | 0.16% | 5.2分 |
| 60 | 佐力药业 | -9.92% | -3.84% | 4.6分 |
| 62 | 众生药业 | -10.24% | 0.25% | 5.9分 |
| 64 | 金花股份 | -11.51% | -2.05% | 5.2分 |
| 66 | *ST长药 | -12.56% | -7.93% | 3.6分 |
| 68 | 九芝堂 | -13.34% | -2.07% | 5.1分 |
| 70 | - | -21.92% | -3.26% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/112 ， 7/112。
[{"date":"2025-06-30","value":"9.34","vol":"3.94"},{"date":"2025-03-31","value":"3.41","vol":"2.20"},{"date":"2024-12-31","value":"17.90","vol":"4.81"},{"date":"2024-09-30","value":"13.17","vol":"2.92"},{"date":"2024-06-30","value":"10.47","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
9.34 | 3.41 | 17.90 | 13.17 | 10.47 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"75.74","vol":"52.43"},{"date":"2025-03-31","value":"77.76","vol":"52.92"},{"date":"2024-12-31","value":"73.41","vol":"52.40"},{"date":"2024-09-30","value":"74.84","vol":"52.75"},{"date":"2024-06-30","value":"74.73","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
75.74 | 77.76 | 73.41 | 74.84 | 74.73 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 37/112 ， 34/112。
[{"date":"2025-06-30","value":"-6.56","vol":"-6.98"},{"date":"2025-03-31","value":"-3.32","vol":"-6.63"},{"date":"2024-12-31","value":"1.03","vol":"-6.97"},{"date":"2024-09-30","value":"-3.49","vol":"-4.57"},{"date":"2024-06-30","value":"-10.53","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-6.56 | -3.32 | 1.03 | -3.49 | -10.53 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-4.70","vol":"2.33"},{"date":"2025-03-31","value":"4.80","vol":"-36.42"},{"date":"2024-12-31","value":"23.79","vol":"-142.71"},{"date":"2024-09-30","value":"-3.28","vol":"63.06"},{"date":"2024-06-30","value":"-20.70","vol":"-13.81"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-4.70 | 4.80 | 23.79 | -3.28 | -20.70 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.81 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 30/112 ， 31/112。
[{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.11","vol":"0.12"},{"date":"2024-12-31","value":"0.54","vol":"0.49"},{"date":"2024-09-30","value":"0.40","vol":"0.37"},{"date":"2024-06-30","value":"0.28","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.11 | 0.54 | 0.40 | 0.28 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.13","vol":"1.17"},{"date":"2025-03-31","value":"0.48","vol":"0.60"},{"date":"2024-12-31","value":"2.51","vol":"2.40"},{"date":"2024-09-30","value":"1.55","vol":"1.79"},{"date":"2024-06-30","value":"1.06","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.13 | 0.48 | 2.51 | 1.55 | 1.06 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 8/112 ， 65/112。
[{"date":"2025-06-30","value":"50.96","vol":"20.17"},{"date":"2025-03-31","value":"9.79","vol":"0.38"},{"date":"2024-12-31","value":"57.26","vol":"15.45"},{"date":"2024-09-30","value":"6.02","vol":"6.15"},{"date":"2024-06-30","value":"30.43","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 50.96 | 9.79 | 57.26 | 6.02 | 30.43 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.65","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.65","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.04","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 2.65 | - | 0.65 | - | 0.04 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/112 ， 50/112。
[{"date":"2025-06-30","value":"2.79","vol":"2.88"},{"date":"2025-03-31","value":"2.99","vol":"2.97"},{"date":"2024-12-31","value":"2.58","vol":"2.86"},{"date":"2024-09-30","value":"3.80","vol":"3.22"},{"date":"2024-06-30","value":"3.31","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.79 | 2.99 | 2.58 | 3.80 | 3.31 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"2.49","vol":"2.11"},{"date":"2025-03-31","value":"2.69","vol":"2.20"},{"date":"2024-12-31","value":"2.33","vol":"2.09"},{"date":"2024-09-30","value":"3.24","vol":"2.40"},{"date":"2024-06-30","value":"2.80","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.49 | 2.69 | 2.33 | 3.24 | 2.80 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 38/112 ， 42/112。
[{"date":"2025-06-30","value":"26.00","vol":"33.91"},{"date":"2025-03-31","value":"27.69","vol":"33.34"},{"date":"2024-12-31","value":"28.88","vol":"34.08"},{"date":"2024-09-30","value":"23.39","vol":"32.93"},{"date":"2024-06-30","value":"22.99","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
26.00 | 27.69 | 28.88 | 23.39 | 22.99 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.35","vol":"0.74"},{"date":"2025-03-31","value":"0.38","vol":"0.72"},{"date":"2024-12-31","value":"0.41","vol":"0.74"},{"date":"2024-09-30","value":"0.31","vol":"3.16"},{"date":"2024-06-30","value":"0.30","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.35 | 0.38 | 0.41 | 0.31 | 0.30 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.44","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.30","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.21","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.22","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.71","blueLineValue":"0.80","type":"YC"}]